Drug · DIN 02170671
METHOTREXATE
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since May 3, 2011; first marketed January 24, 1997.
- Drug Identification Number (DIN)
- 02170671
- Company (DIN owner)
- Pfizer Canada UlcKirkland, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Intramuscular; Intravenous; Intra-Arterial
- Therapeutic class (ATC)
- Methotrexate L01BA01
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| METHOTREXATE | 25 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- May 2, 2011: NOC 12304New Drug Submission (NDS) · Manufacturer name change
- April 7, 2003: NOC 2857New Drug Submission (NDS) · Manufacturer name change
- July 31, 1995: NOC 5139New Drug Submission (NDS)
Other DINs named METHOTREXATE
- DIN 02283697 · Approved